2024-06-18 10:00:00 ET
When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY) .
Both companies have a long history of paying dividends and offer attractive yields, making them popular choices among income-seeking investors. However, when comparing these two stocks, several factors should be considered to determine which one is the better high-yield dividend investment.
Image Source: Getty Images.
For further details see:
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb